SCHEMBL12282569

SCHEMBL12282569

CCOC(COc1ccc(/C(=C(/CCCl)c2ccccc2)c2ccc(OCc3ccc(OC)cc3)cc2)cc1)OCC

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.49
▸ HTR6 P50406 1/20 0.49
▸ ESR1 P03372 4/20 0.48
▸ ESRRG P62508 3/20 0.48
▸ CYP19A1 P11511 2/20 0.48
▸ ESR2 Q92731 2/20 0.48
▸ RAB9A P51151 2/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ POLB P06746 1/20 0.44
▸ FFAR1 O14842 2/20 0.43
▸ PTGS2 P35354 2/20 0.42
▸ ABCG2 Q9UNQ0 1/20 0.40
▸ PLA2G4B P0C869 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ PPARG P37231 1/20 0.39
▸ PPARD Q03181 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12134462 0.90 PTGS2 (0.51) HTR6ESR1ESRRGCYP19A1ESR2
SCHEMBL12284881 0.85 ESR1 (0.65) LMNAHTR6ESR1ESRRGCYP19A1
SCHEMBL9860167 0.80 ESR1 (0.66) LMNAHTR6ESR1ESRRGCYP19A1
SCHEMBL9860174 0.80 ESR1 (0.66) LMNAHTR6ESR1ESRRGCYP19A1
SCHEMBL9860177 0.80 ESR1 (0.66) LMNAHTR6ESR1ESRRGCYP19A1
SCHEMBL17506016 0.79 LMNA (0.64) LMNAHTR6ESR1ESRRGCYP19A1
SCHEMBL17506017 0.79 LMNA (0.64) LMNAHTR6ESR1ESRRGCYP19A1
SCHEMBL17506015 0.79 LMNA (0.64) LMNAHTR6ESR1ESRRGCYP19A1
SCHEMBL12282316 0.79 ESR1 (0.65) LMNAHTR6ESR1ESRRGCYP19A1
SCHEMBL13971003 0.76 HTR6 (0.69) LMNAHTR6ESR1ESRRGCYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011129837-A1 USE OF A 4-HYDROXYTOREMIFENE PRODRUG FOR TREATMENT OF BREAST CANCER OLEMA PHARMACEUTICALS, INC. (US) 2011-10-20 — — WO disclosed
Send feedback